Table 1.

Baseline patient characteristics

Baseline screening
Total enrolled11
Age (y)53 (40-66)
Sex, female11
    African American3
    Middle Eastern1
Body surface area (m2)1.91 (1.54-2.37)
Metastatic disease sites
    Lung3 (27%)
    Liver4 (36%)
    Bone6 (54%)
    Other7 (63%)
No. prior metastatic chemotherapy regimens4 (0-8)
ECOG performance status1 (0-1)
Pretherapy chemistry
    Alanine aminotransferase (units/L)22 (11-49)
    Aspartate aminotransferase (units/L)21 (12-41)
    Total bilirubin (mg/dL)0.48 (0.2-1.1)
    Serum creatinine (mg/dL)0.78 (0.6-1.1)
  • NOTE: ECOG, Eastern Cooperative Oncology Group. Continuous data are given as median with range in parentheses, and categorical data as number of patients with percentage of the total population in parentheses.